PAREXEL International (United Kingdom)

PAREXEL International (United Kingdom)

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for PAREXEL International (United Kingdom), United Kingdom, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

72%


Total
Publications

613


Total Open
Publications

441


Total
Citations

7.7K


Open Access
Percentage

72%


Total
Publications

613


Total Open
Publications

441


Total
Citations

7.7K

Wikipedia

Website

download

Breakdown

53% 16% 3% 28%

Publisher Open

53%

Both

16%

Other Platform Open

3%

Closed

28%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

12%OA Journal

OA Journal 12%

51

Hybrid 76%

324

No Guarantees 12%

49

Other Platform Open

Domain 82%

94

Institution 23%

27

Public 12%

14

Other Internet 8%

9

Preprint 3%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
94
Europe PMC
Domain
49
University College London - UCL Discovery
Institution
10
Semantic Scholar
Public
10
whiterose.ac.uk OAI-PMH Repository
Institution
6
University of Birmingham - University of Birmingham Research Portal
Institution
5
Figshare
Public
5
Ghent University - Ghent University Academic Bibliography
Institution
4
University of Southampton - ePrints Soton
Institution
3
Erasmus University Rotterdam - EUR Research Repository
Institution
3
1 / 4

Data updated 8 December 2024

Share

Share

Share